Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo

A meta-analysis

Young Ho Lee, S. C. Bae

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We investigated whether the tumor necrosis factor-α (TNF-α) promoter -238 A/G and -308 A/G polymorphisms are associated with rheumatoid arthritis (RA) and vitiligo susceptibility. MEDLINE and EMBASE databases and a manual search were used to identify articles in which TNF-α polymorphisms were determined in RA or vitiligo patients and controls. Meta-analysis was used to examine the associations between the TNF-α -238 A/G polymorphism and RA and vitiligo using the allelic contrast and dominant models. Fifteen studies (10 RA and 5 vitiligo) involving 3678 cases and 4400 controls were considered. We observed an association between the TNF-α -238 A allele and RA when all subjects were considered [odds ratio (OR) = 0.686, 95% confidence interval (CI) = 0.476-0.968, P = 0.043]. After stratification by ethnicity, we found no association between the TNF-α -238 A allele and RA in European or Asian populations. We observed no association between the TNF-α -308 A allele and vitiligo (OR = 1.787, 95%CI = 0.894-3.573, P = 0.101). However, the adjusted OR by the trim-and-fill technique was significant (OR = 2.064, 95%CI = 1.138-3.743). After stratification by geographic continent, the TNF-α -308 A allele was significantly associated with vitiligo in Middle Eastern populations (OR = 1.569, 95%CI = 1.224-2.013, P = 3.8 x 10-5). The TNF-α -238 A/G polymorphism was associated with RA susceptibility, and the TNF-α -308 A/G polymorphism may be a significant risk factor for vitiligo in Middle Eastern populations.

Original languageEnglish
Pages (from-to)5548-5559
Number of pages12
JournalGenetics and Molecular Research
Volume14
Issue number2
DOIs
Publication statusPublished - 2015 May 25

Fingerprint

Vitiligo
Meta-Analysis
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Odds Ratio
Alleles
Confidence Intervals
Population
MEDLINE
Databases

Keywords

  • Meta-analysis
  • Polymorphism
  • Rheumatoid arthritis
  • Tumor necrosis factor
  • Vitiligo

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo : A meta-analysis. / Lee, Young Ho; Bae, S. C.

In: Genetics and Molecular Research, Vol. 14, No. 2, 25.05.2015, p. 5548-5559.

Research output: Contribution to journalArticle

@article{f4591eb8526c4498ac126e3bf7b5c62b,
title = "Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: A meta-analysis",
abstract = "We investigated whether the tumor necrosis factor-α (TNF-α) promoter -238 A/G and -308 A/G polymorphisms are associated with rheumatoid arthritis (RA) and vitiligo susceptibility. MEDLINE and EMBASE databases and a manual search were used to identify articles in which TNF-α polymorphisms were determined in RA or vitiligo patients and controls. Meta-analysis was used to examine the associations between the TNF-α -238 A/G polymorphism and RA and vitiligo using the allelic contrast and dominant models. Fifteen studies (10 RA and 5 vitiligo) involving 3678 cases and 4400 controls were considered. We observed an association between the TNF-α -238 A allele and RA when all subjects were considered [odds ratio (OR) = 0.686, 95{\%} confidence interval (CI) = 0.476-0.968, P = 0.043]. After stratification by ethnicity, we found no association between the TNF-α -238 A allele and RA in European or Asian populations. We observed no association between the TNF-α -308 A allele and vitiligo (OR = 1.787, 95{\%}CI = 0.894-3.573, P = 0.101). However, the adjusted OR by the trim-and-fill technique was significant (OR = 2.064, 95{\%}CI = 1.138-3.743). After stratification by geographic continent, the TNF-α -308 A allele was significantly associated with vitiligo in Middle Eastern populations (OR = 1.569, 95{\%}CI = 1.224-2.013, P = 3.8 x 10-5). The TNF-α -238 A/G polymorphism was associated with RA susceptibility, and the TNF-α -308 A/G polymorphism may be a significant risk factor for vitiligo in Middle Eastern populations.",
keywords = "Meta-analysis, Polymorphism, Rheumatoid arthritis, Tumor necrosis factor, Vitiligo",
author = "Lee, {Young Ho} and Bae, {S. C.}",
year = "2015",
month = "5",
day = "25",
doi = "10.4238/2015.May.25.6",
language = "English",
volume = "14",
pages = "5548--5559",
journal = "Genetics and Molecular Research",
issn = "1676-5680",
publisher = "Fundacao de Pesquisas Cientificas de Ribeirao Preto",
number = "2",

}

TY - JOUR

T1 - Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo

T2 - A meta-analysis

AU - Lee, Young Ho

AU - Bae, S. C.

PY - 2015/5/25

Y1 - 2015/5/25

N2 - We investigated whether the tumor necrosis factor-α (TNF-α) promoter -238 A/G and -308 A/G polymorphisms are associated with rheumatoid arthritis (RA) and vitiligo susceptibility. MEDLINE and EMBASE databases and a manual search were used to identify articles in which TNF-α polymorphisms were determined in RA or vitiligo patients and controls. Meta-analysis was used to examine the associations between the TNF-α -238 A/G polymorphism and RA and vitiligo using the allelic contrast and dominant models. Fifteen studies (10 RA and 5 vitiligo) involving 3678 cases and 4400 controls were considered. We observed an association between the TNF-α -238 A allele and RA when all subjects were considered [odds ratio (OR) = 0.686, 95% confidence interval (CI) = 0.476-0.968, P = 0.043]. After stratification by ethnicity, we found no association between the TNF-α -238 A allele and RA in European or Asian populations. We observed no association between the TNF-α -308 A allele and vitiligo (OR = 1.787, 95%CI = 0.894-3.573, P = 0.101). However, the adjusted OR by the trim-and-fill technique was significant (OR = 2.064, 95%CI = 1.138-3.743). After stratification by geographic continent, the TNF-α -308 A allele was significantly associated with vitiligo in Middle Eastern populations (OR = 1.569, 95%CI = 1.224-2.013, P = 3.8 x 10-5). The TNF-α -238 A/G polymorphism was associated with RA susceptibility, and the TNF-α -308 A/G polymorphism may be a significant risk factor for vitiligo in Middle Eastern populations.

AB - We investigated whether the tumor necrosis factor-α (TNF-α) promoter -238 A/G and -308 A/G polymorphisms are associated with rheumatoid arthritis (RA) and vitiligo susceptibility. MEDLINE and EMBASE databases and a manual search were used to identify articles in which TNF-α polymorphisms were determined in RA or vitiligo patients and controls. Meta-analysis was used to examine the associations between the TNF-α -238 A/G polymorphism and RA and vitiligo using the allelic contrast and dominant models. Fifteen studies (10 RA and 5 vitiligo) involving 3678 cases and 4400 controls were considered. We observed an association between the TNF-α -238 A allele and RA when all subjects were considered [odds ratio (OR) = 0.686, 95% confidence interval (CI) = 0.476-0.968, P = 0.043]. After stratification by ethnicity, we found no association between the TNF-α -238 A allele and RA in European or Asian populations. We observed no association between the TNF-α -308 A allele and vitiligo (OR = 1.787, 95%CI = 0.894-3.573, P = 0.101). However, the adjusted OR by the trim-and-fill technique was significant (OR = 2.064, 95%CI = 1.138-3.743). After stratification by geographic continent, the TNF-α -308 A allele was significantly associated with vitiligo in Middle Eastern populations (OR = 1.569, 95%CI = 1.224-2.013, P = 3.8 x 10-5). The TNF-α -238 A/G polymorphism was associated with RA susceptibility, and the TNF-α -308 A/G polymorphism may be a significant risk factor for vitiligo in Middle Eastern populations.

KW - Meta-analysis

KW - Polymorphism

KW - Rheumatoid arthritis

KW - Tumor necrosis factor

KW - Vitiligo

UR - http://www.scopus.com/inward/record.url?scp=84930009730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930009730&partnerID=8YFLogxK

U2 - 10.4238/2015.May.25.6

DO - 10.4238/2015.May.25.6

M3 - Article

VL - 14

SP - 5548

EP - 5559

JO - Genetics and Molecular Research

JF - Genetics and Molecular Research

SN - 1676-5680

IS - 2

ER -